Quantum Computing, Venture Capital, Founders Spotlight, Biotechnology, Science.
out of reach of traditional high performance computing. Simulation (not just machine learning) is needed because of the lack of data for most targets/ligands of interest in biologics. Less than 10% of biologic discovery programs in large pharma use computational tools/chemists and we thought that